Sanofi deepens cancer drive with $1.2 billion of deals, Innate jumps
PARIS Sanofi boosted its presence in cancer research on Monday by signing two deals with biotech companies worth up to $1.2 billion, as the French drugmaker plays catch-up with rivals in the hot research field. Shares in French biotech group Innate Pharma, one... More »
